BNTX Projected Dividend Yield

ADS/BioNTech SE ( NASDAQ : BNTX )

BioNTech develops immunotherapies for cancer and other diseases. Co.'s immunotherapy product candidates span the following four drug classes: messenger ribonucleic acid (mRNA) therapeutics, in which it is utilizing mRNA to deliver genetic information to cells; cell therapies, in which it is developing a range of cell therapies, including chimeric antigen receptorT cells, neoantigen-based T cell therapies and T cell receptor therapies; antibodies, in which it is developing antibodies that are designed to target immune checkpoints that modulate the patient's immune response to cancer; and small molecule immunomodulators, which is for the treatment of solid tumors in clinical testing.

12 YEAR PERFORMANCE RESULTS

BNTX Dividend History Detail
BNTX Dividend News
BNTX Competitors News
# of Shares: 0 Closing Price: 92.97 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2023 0.00 0% 0 $ 0.00 0.00%
2024 1.55 0% 0 $ 0.00 1.67%
2025 0.00 0% 0 $ 0.00 1.67%
2026 0.00 0% 0 $ 0.00 1.67%
2027 0.00 0% 0 $ 0.00 1.67%
2028 0.00 0% 0 $ 0.00 1.67%
2029 0.00 0% 0 $ 0.00 1.67%
2030 0.00 0% 0 $ 0.00 1.67%
2031 0.00 0% 0 $ 0.00 1.67%
2032 0.00 0% 0 $ 0.00 1.67%
2033 0.00 0% 0 $ 0.00 1.67%
2034 0.00 0% 0 $ 0.00 1.67%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 1.67%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 1.55
Dividend 1 Yr Growth = ( 0.00 – 1.55 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
1.55
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2022
N/A
Jun 02, 2022
Jun 03, 2022
Jun 17, 2022
1.5498
2022 Total:
1.5498
X
Search Dividend Investor